Content
03/26/2025
Los Gatos, CA USA
Supira Medical
completed $120 million Series E Round funding. Investors include
Qatar Investment Authority (lead), Novo Holdings (lead), Cormorant Asset Management, The Capital Partnership, 415 Capital, AMED Ventures, Unorthodox Ventures.
About
Supira Medical is a clinical-stage Shifamed portfolio company focused on the development of a next-generation pVAD for use in high-risk patients undergoing interventional procedures and experiencing cardiogenic shock. To date, the Supira System has benefited 85 HRPCI patients.
Startup
Sector:
MedTech
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
